Anthony G Marson Selected Research

Partial Epilepsies (Epilepsy, Partial)

1/2022	Brivaracetam add-on therapy for drug-resistant epilepsy.
1/2022	Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
1/2022	Pregabalin add-on for drug-resistant focal epilepsy.
1/2022	Vagus nerve stimulation for focal seizures.
12/2021	Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
12/2021	Gabapentin add-on treatment for drug-resistant focal epilepsy.
1/2021	Antidepressants for people with epilepsy and depression.
1/2021	Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy.
11/2020	Rufinamide add-on therapy for drug-resistant epilepsy.
6/2020	Levetiracetam add-on for drug-resistant focal epilepsy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anthony G Marson Research Topics

Disease

111	Epilepsy (Aura) 05/2022 - 05/2002
94	Seizures (Absence Seizure) 01/2022 - 05/2002
50	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 03/2007
23	Drug Resistant Epilepsy 01/2022 - 07/2008
22	Dizziness (Lightheadedness) 01/2022 - 07/2008
15	Sleepiness 01/2022 - 07/2008
13	Fatigue 01/2022 - 07/2008
11	Ataxia (Dyssynergia) 01/2022 - 07/2008
10	Diplopia (Double Vision) 11/2020 - 01/2010
9	Nausea 01/2021 - 07/2008
7	Temporal Lobe Epilepsy 10/2017 - 01/2009
6	Headache (Headaches) 01/2022 - 01/2018
4	Weight Gain 01/2022 - 03/2014
4	Juvenile Myoclonic Epilepsy 09/2019 - 08/2010
4	Infantile Spasms (West Syndrome) 01/2019 - 12/2010
3	Myoclonus (Nocturnal Myoclonus) 01/2022 - 01/2017
3	Hypersensitivity (Allergy) 01/2021 - 01/2017
3	Vomiting 11/2020 - 06/2015
3	Glioblastoma (Glioblastoma Multiforme) 03/2020 - 01/2017
3	Epileptic Syndromes 01/2020 - 01/2017
3	Tremor (Tremors) 10/2019 - 05/2012
3	Glioma (Gliomas) 05/2018 - 01/2017
2	Atrophy 05/2022 - 12/2021
2	Gingival Hyperplasia 01/2021 - 03/2014
2	Rolandic Epilepsy (Centrotemporal Epilepsy) 01/2021 - 03/2014
2	Lennox Gastaut Syndrome 11/2020 - 01/2018
2	Hypoventilation 01/2020 - 07/2016
2	Exanthema (Rash) 01/2020 - 01/2018
2	Sudden Unexpected Death in Epilepsy 01/2020 - 07/2016
2	Airway Obstruction (Choking) 01/2020 - 07/2016
2	Weight Loss (Weight Reduction) 10/2019 - 02/2014
2	Hyperplasia 10/2018 - 01/2018
2	Drug-Related Side Effects and Adverse Reactions 01/2018 - 04/2015
2	Soft Tissue Infections 01/2017 - 06/2014
2	Cognitive Dysfunction 01/2016 - 09/2014
2	Intellectual Disability (Idiocy) 09/2015 - 09/2015
2	Infections 09/2014 - 09/2012
2	Acidosis 05/2011 - 11/2009
1	Idiopathic Generalized Epilepsy 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021
1	Autoimmune Diseases of the Nervous System 08/2020
1	Generalized Epilepsy 01/2020

Drug/Important Bio-Agent (IBA)

94	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022 - 04/2006
77	Pharmaceutical PreparationsIBA 01/2022 - 09/2002
40	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022 - 05/2002
27	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 05/2002
23	Phenytoin (Dilantin)FDA LinkGeneric 01/2022 - 11/2007
23	Lamotrigine (Lamictal)FDA LinkGeneric 01/2022 - 03/2005
21	Topiramate (Topamax)FDA LinkGeneric 01/2022 - 03/2007
18	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 01/2009
14	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2009
13	Gabapentin (Neurontin)FDA LinkGeneric 01/2022 - 03/2007
12	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2022 - 03/2007
10	Zonisamide (Zonegran)FDA LinkGeneric 01/2022 - 01/2009
7	Vigabatrin FDA Link 01/2020 - 07/2008
6	Tiagabine (Gabitril)FDA Link 10/2019 - 01/2009
5	Lacosamide FDA Link 01/2022 - 06/2010
5	sulthiame (sultiam)IBA 01/2021 - 03/2013
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2007
4	Pregabalin (Lyrica)FDA Link 01/2022 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2021 - 12/2014
3	Immunoglobulin E (IgE)IBA 05/2022 - 12/2021
3	rufinamide FDA Link 01/2022 - 01/2018
3	Antidepressive Agents (Antidepressants)IBA 01/2021 - 02/2014
3	Pyridoxine (Pyridoxin)FDA LinkGeneric 01/2019 - 03/2013
2	brivaracetamIBA 01/2022 - 01/2019
2	Biological ProductsIBA 01/2021 - 08/2015
2	TriazolesIBA 11/2020 - 01/2018
2	AntibodiesIBA 08/2020 - 09/2014
2	Adenosine (Adenocard)FDA LinkGeneric 01/2020 - 07/2016
2	Opiate AlkaloidsIBA 01/2020 - 07/2016
2	Opioid Analgesics (Opioids)IBA 01/2020 - 07/2016
2	SodiumIBA 03/2019 - 01/2018
2	HLA-A31 antigenIBA 01/2018 - 04/2015
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 06/2014
2	losigame (A033)IBA 05/2011 - 06/2010
2	ezogabine (retigabine)IBA 05/2011 - 06/2010
2	Allopurinol (Remid)FDA LinkGeneric 05/2011 - 06/2010
2	eslicarbazepineIBA 05/2011 - 06/2010
1	eslicarbazepine acetateIBA 01/2022
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 08/2020
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 08/2020
1	Clobazam (HR 376)IBA 10/2019

Therapy/Procedure

33	Therapeutics 01/2022 - 08/2006
17	Time-to-Treatment 01/2022 - 03/2007
16	Drug Therapy (Chemotherapy) 11/2020 - 10/2014
5	Vagus Nerve Stimulation 01/2022 - 01/2009
5	Ketogenic Diet 03/2020 - 01/2017
4	Craniotomy 01/2020 - 02/2013
3	Aftercare (After-Treatment) 01/2021 - 06/2007
3	Hemispherectomy 02/2012 - 01/2009
3	Relaxation Therapy (Relaxation Technique) 05/2011 - 01/2009
3	Psychology Biofeedback (Biofeedback) 05/2011 - 01/2009
2	First Aid (Aids, First) 01/2020 - 01/2017
2	Protective Devices (Safety Device) 01/2020 - 07/2016
2	Duration of Therapy 01/2019 - 05/2011
2	Electrodes (Electrode) 01/2017 - 06/2014
1	Ambulatory Care (Outpatient Care) 11/2019